del Rincon SV - Search Results

1

The novel arsenical darinaparsin is transported by cystine importing systems.

Garnier N, Redstone GG, Dahabieh MS, Nichol JN, del Rincon SV, Gu Y, Bohle DS, Sun Y, Conklin DS, Mann KK, Miller WH Jr. Garnier N, et al. Among authors: del rincon sv. Mol Pharmacol. 2014 Apr;85(4):576-85. doi: 10.1124/mol.113.089433. Epub 2014 Jan 15. Mol Pharmacol. 2014. PMID: 24431147

2

Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway.

del Rincón SV, Rousseau C, Samanta R, Miller WH Jr. del Rincón SV, et al. Oncogene. 2003 May 29;22(22):3353-60. doi: 10.1038/sj.onc.1206485. Oncogene. 2003. PMID: 12776186

3

Expression of SMRTbeta promotes ligand-induced activation of mutated and wild-type retinoid receptors.

Côté S, McNamara S, Brambilla D, Bianchini A, Rizzo G, del Rincón SV, Grignani F, Nervi C, Miller WH Jr. Côté S, et al. Among authors: del rincon sv. Blood. 2004 Dec 15;104(13):4226-35. doi: 10.1182/blood-2003-10-3583. Epub 2004 Aug 19. Blood. 2004. PMID: 15319284 Free article.

4

Retinoic acid mediates degradation of IRS-1 by the ubiquitin-proteasome pathway, via a PKC-dependant mechanism.

del Rincón SV, Guo Q, Morelli C, Shiu HY, Surmacz E, Miller WH. del Rincón SV, et al. Oncogene. 2004 Dec 9;23(57):9269-79. doi: 10.1038/sj.onc.1208104. Oncogene. 2004. PMID: 15516986

5

Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance.

Dupéré-Richer D, Kinal M, Ménasché V, Nielsen TH, Del Rincon S, Pettersson F, Miller WH Jr. Dupéré-Richer D, et al. Cell Death Dis. 2013 Feb 7;4(2):e486. doi: 10.1038/cddis.2012.210. Cell Death Dis. 2013. PMID: 23392174 Free PMC article.

6

The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cells.

Garnier N, Petruccelli LA, Molina MF, Kourelis M, Kwan S, Diaz Z, Schipper HM, Gupta A, del Rincon SV, Mann KK, Miller WH Jr. Garnier N, et al. Among authors: del rincon sv. Leukemia. 2013 Nov;27(11):2220-8. doi: 10.1038/leu.2013.54. Epub 2013 Feb 21. Leukemia. 2013. PMID: 23426167

7

Expression of leukemia-associated fusion proteins increases sensitivity to histone deacetylase inhibitor-induced DNA damage and apoptosis.

Petruccelli LA, Pettersson F, Del Rincón SV, Guilbert C, Licht JD, Miller WH Jr. Petruccelli LA, et al. Among authors: del rincon sv. Mol Cancer Ther. 2013 Aug;12(8):1591-604. doi: 10.1158/1535-7163.MCT-12-1039. Epub 2013 Mar 27. Mol Cancer Ther. 2013. PMID: 23536727

8

Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3.

Robichaud N, del Rincon SV, Huor B, Alain T, Petruccelli LA, Hearnden J, Goncalves C, Grotegut S, Spruck CH, Furic L, Larsson O, Muller WJ, Miller WH, Sonenberg N. Robichaud N, et al. Among authors: del rincon sv. Oncogene. 2015 Apr 16;34(16):2032-42. doi: 10.1038/onc.2014.146. Epub 2014 Jun 9. Oncogene. 2015. PMID: 24909168 Free PMC article.

9

Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond.

Pettersson F, Del Rincon SV, Miller WH Jr. Pettersson F, et al. Among authors: del rincon sv. Expert Opin Ther Targets. 2014 Sep;18(9):1035-48. doi: 10.1517/14728222.2014.937426. Epub 2014 Jul 8. Expert Opin Ther Targets. 2014. PMID: 25004955 Review.

10

Genetic and pharmacologic inhibition of eIF4E reduces breast cancer cell migration, invasion, and metastasis.

Pettersson F, Del Rincon SV, Emond A, Huor B, Ngan E, Ng J, Dobocan MC, Siegel PM, Miller WH Jr. Pettersson F, et al. Among authors: del rincon sv. Cancer Res. 2015 Mar 15;75(6):1102-12. doi: 10.1158/0008-5472.CAN-14-1996. Epub 2015 Jan 21. Cancer Res. 2015. PMID: 25608710

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page